EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for MBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.1592
March 31, 2026 -0.1419
December 31, 2025 -0.0737
September 30, 2025 -0.075
June 30, 2025 -0.1895
March 31, 2025 -0.0535
December 31, 2024 -0.9495
September 30, 2024 -0.0383
June 30, 2024 -0.3546
March 31, 2024 -0.4613
December 31, 2023 -0.9345
September 30, 2023 -1.231
June 30, 2023 -1.998
March 31, 2023 -2.062
December 31, 2022 -2.744
September 30, 2022 -2.690
June 30, 2022 -2.783
March 31, 2022 -3.033
December 31, 2021 -3.185
September 30, 2021 -2.799
June 30, 2021 -2.460
Date Value
March 31, 2021 -2.788
December 31, 2020 -4.833
September 30, 2020 -3.393
June 30, 2020 -4.863
March 31, 2020 -4.238
December 31, 2019 -6.041
September 30, 2019 -3.825
June 30, 2019 -4.296
March 31, 2019 -5.160
December 31, 2018 -6.394
September 30, 2018 -4.154
June 30, 2018 -2.820
March 31, 2018 -178.52
December 31, 2017 -8.920
September 30, 2017 -4.05
June 30, 2017 -3.15
March 31, 2017 -2.10
December 31, 2016 -9.60
September 30, 2016 -2.85
June 30, 2016 -1.65
March 31, 2016 -1.35

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics